To imagine the impossible,
takes both brilliant minds and a vision.

We’re proud to say our team is made up of just that — people and minds both driven by passion
and full of potential. Our company is led by a team of executives and directors with vast experience
and proven track records in pain, drug development and commercialization.

 
 

Executive Management team

D. LYNN KIRKPATRICK, PHD

Chief Executive Officer

“Turning a ship in a storm is never easy. We have been weathering the opioid crisis and will soon have the wind behind us!”
 
“As crisis and consolidation occur in the opioid sector, Ensysce is positioned to become both best in class and market leader in abuse deterrence through safety efficacy and competitive pricing to generics.”

RICHARD WRIGHT, MSE, MBA

Chief Business Officer

 

KURT SCHMIDT, MBA

Chief Financial Officer

“Lorem ipsum dolor sit amet, est vocent iracundia ut, augue.”
 
“Being able to protect against opioid overdose – using MPAR technology – is a disruptive technology that will set Ensysce apart from all other conventional and abuse-deterrent opioid products.”

WILLIAM SCHMIDT, PHD

Chief Medical Officer

 

GEOFF BIRKETT

Chief Commercial Officer

“We are fighting a war against pain and dangerous opioids. We need to change the rules of engagement. Formulations haven’t worked so we went back to basic chemistry.”
 
“Sed purus sem, scelerisque ac rhoncus eget, porttitor nec odio. Lorem ipsum dolor sit amet.”

JEFFREY MILLARD, PHD

Chief Operating Officer